Charnita Zeigler-Johnson, PhD, MPH
The Franklin Building, Suite 314
Philadelphia, PA 19107
(215) 503-9506 fax
Most Recent Peer-reviewed Publications
- Evaluation of 4, 672 routine prostate biopsies performed in six African countries
- Gender- and ethnic-specific associations with obesity: Individual and neighborhood-level factors
- Relationship of early-onset baldness to prostate cancer in african-american men
- What stresses men? predictors of perceived stress in a population-based multi-ethnic cross sectional cohort
- Relationship of obesity, Androgen receptor genotypes and biochemical failure after radical prostatectomy
Post-Doc, University of Pennsylvania, Philadelphia, PA - 2004
Research & Clinical Interests
Dr. Charnita Zeigler-Johnson studies prostate cancer disparities and risk factors that influence prostate cancer occurrence, progression and treatment outcomes. These risk factors include genetic polymorphisms, inflammation biomarkers, race/ethnicity, obesity, baldness, socioeconomic status and neighborhood characteristics. Her research goals are to identify possible modes of cancer prevention in high-risk populations and to provide new understanding about how contextual factors influence disease outcomes.
Dr. Zeigler-Johnson received M.P.H. and Ph.D. degrees in epidemiology from the Graduate School of Public Health at the University of Pittsburgh. She completed her post-doctoral work in molecular epidemiology at the University of Pennsylvania where she is an Adjunct Scholar in the Center for Clinical Epidemiology and Biostatistics. Dr. Zeigler-Johnson serves as co-investigator for the Study of Clinical Outcomes, Risk and Ethnicity and research collaborator for the PROGRÈS Study in Senegal, West Africa. Dr. Zeigler-Johnson is also a member of the Men of African Descent and Prostate Cancer Consortium and the African-Caribbean Cancer Consortium.